Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.

× No keyword cloud information.

5 in total

1. Fatal hepatitis B reactivation in a patient with islet cell tumor on octreotide and sirolimus.

Authors: Ersilia M DeFilippis; Emmy Ludwig
Journal: J Gastrointest Oncol Date: 2015-10

2. Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.

Authors: Shigeru Kusumoto; Luca Arcaini; Xiaonan Hong; Jie Jin; Won Seog Kim; Yok Lam Kwong; Marion G Peters; Yasuhito Tanaka; Andrew D Zelenetz; Hiroshi Kuriki; Günter Fingerle-Rowson; Tina Nielsen; Eisuke Ueda; Hanna Piper-Lepoutre; Gila Sellam; Kensei Tobinai
Journal: Blood Date: 2018-10-19 Impact factor: 22.113

Review 3. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations.

Authors: Fernando Bessone; Melisa Dirchwolf
Journal: World J Hepatol Date: 2016-03-18

4. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.

Authors: Jessica P Hwang; Mark R Somerfield; Devena E Alston-Johnson; Donna R Cryer; Jordan J Feld; Barnett S Kramer; Anita L Sabichi; Sandra L Wong; Andrew S Artz
Journal: J Clin Oncol Date: 2015-05-11 Impact factor: 44.544

Review 5. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.

Authors: Dimitrios C Ziogas; Frosso Kostantinou; Evangelos Cholongitas; Amalia Anastasopoulou; Panagiotis Diamantopoulos; John Haanen; Helen Gogas
Journal: J Immunother Cancer Date: 2020-10 Impact factor: 13.751

5 in total